BioCardia, Inc.

Sep 24, 2018

Positive Data On BioCardia's Investigational CardiAMP Cell Therapy For Heart Failure Presented At Transcatheter Cardiovascular Therapeutics (TCT) Conference

Sep 14, 2018

BioCardia Receives Two New U.S. Patents

Sep 05, 2018

Additional Results From BioCardia's Phase III Pivotal CardiAMP Heart Failure Trial To Be Presented At Three Influential Fall Cardiovascular Congresses

Aug 22, 2018

Preliminary Results From BioCardia's Phase III Pivotal CardiAMP Heart Failure Trial Reported In Circulation Research Journal

Aug 09, 2018

BioCardia, Inc. Reports Second Quarter 2018 Financial Results and Business Highlights

Apr 25, 2018

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

Apr 18, 2018

BioCardia Presents at Alliance for Regenerative Medicine's (ARM's) Annual Cell & Gene Therapy Investor Day

Apr 09, 2018

Phase III CardiAMP Heart Failure Trial Featured in American Heart Journal